Muscarinic antagonist&o=10616

Muscarinic antagonist

A muscarinic receptor antagonist is an agent that reduces the activity of the muscarinic acetylcholine receptor. Most of them are synthetic, but scopolamine and atropine are belladonna alkaloids, and are naturally extracted.

Effects

Effect on CNS

Muscarinic antagonists stimulate the CNS as a result of stimulation of medulla and higher cerebral centers. At low doses of atropine, it causes slight restlessness; at high or toxic doses it causes restlessness, agitation, and hallucinations. In atropine poisoning, marked excitation and agitation leads to hyperactivity and increase in body temperature through inhibition of sweating. Scopolamine in therapeutic doses causes CNS depression characterized by amnesia, fatigue and reduction in REM (Rapid Eye Movement) sleep. Hyoscine has anti-emetic activity, so is used in motion sickness.

Antimuscarinics are also used as anti-parkinsonian drugs. In Parkinsonism, there is imbalance between levels of acetylcholine and dopamine in the brain, involving both increased levels of acetylcholine and degeneration of dopaminergic pathways (nigro-striatal pathway). Thus, in Parkinsonism there is decreased level of dopaminergic activity. One method of balancing the neurotransmitters is through blocking central cholinergic activity using muscarinic receptor antagonists.

Effect on heart

Atropine acts on the M2-receptors of the heart and antagonizes the activity of Ach. It causes tachycardia by blocking vagal effects on the SA node. Ach hyperpolarizes the SA node which is overcome by MRA and thus increases the heart rate. If atropine is given by intramuscular or subcutaneous, it causes initial bradycardia. This is because by i.m/s.c it acts on presynaptic M1-receptors (auto receptors). Intake of Ach in axoplasm is prevented and the presynaptic nerve releases more Ach into the synapse which initially causes bradycardia.

In the AV node, the resting potential (RP) is abbreviated which facilitates conduction. This is seen as a shortened PR-interval on EKG.

It has an opposite effect on Blood Pressure. Tachycardia and stimulation of the vasomotor center causes an increase in BP. But due to feed back regulation of VMC there is fall in BP due to vasodilation.

Important muscarinic antagonists include atropine, hyoscine, ipratropium, tropicamide, cyclopentolate and pirenzepine...

Comparison table

Substance Trade names Mechanism Clinical use Adverse effects
Atropine (D/L-Hyoscyamine) non-selective antagonism, CNS stimulation

  • urinary retention
  • xerostomia
  • blurred vision
  • Scopolamine (L-Hyoscine) non-selective antagonism, CNS depression

  • as atropine
  • sedation
  • Ipratropium non-selective antagonism, without any mucociliary excretion inhibition.

    Tropicamide short acting non-selective antagonism, CNS depression

  • may cause ocular hypertension
  • Pirenzepine M1 receptor-selective antagonist
  • in peptic ulcer (not much anymore)
  • (fewer than non-selective ones)
    Diphenhydramine Benadryl

    Dimenhydrinate Dramamine

    Dicyclomine
    Flavoxate
    Oxybutynin
    Tiotropium Spiriva

    Cyclopentolate short acting non-selective antagonism, CNS depression

  • may cause ocular hypertension
  • Atropine methonitrate non-selective antagonism, blocks transmission in ganglia

    * *
    Trihexyphenidyl Artane
    Tolterodine Detrusitol
    Solifenacin Vesicare
    Darifenacin Enablex
    Benzatropine Cogentin Reduces the effects of the relative central cholinergic excess that occurs as a result of dopamine deficiency. Anti-Parkinsonian Drug
    Mebeverine Colofac

    See also

  • Muscarinic agonist
  • Parasympatholytic
  • Anticholinergic
  • References

    External links

    Search another word or see Muscarinic antagonist&o=10616on Dictionary | Thesaurus |Spanish
    • Please Login or Sign Up to use the Recent Searches feature
    FAVORITES
    RECENT